Watchlist
Loading...
US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
168.250 +4.240+2.59% Close 11/30 16:00 ET
168.600+0.350+0.21% Pre 06:34 ET
169.649High165.530Low780.58KVolume
Pre-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Alnylam Pharmaceuticals Company

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Revenue Breakdown

Business Currency:USD
2022/12/31
Stock NameRevenueRatio
ONPATTRO557.61M53.75%
GIVLAARI173.14M16.69%
Net revenues from collaborations134.91M13.00%
AMVUTTRA93.8M9.04%
OXLUMO69.78M6.73%
Royalty revenue8.18M0.79%
View all

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >